| LICOX | MDIHX | LICOX / MDIHX | |
| Total Expense Ratio | 0.62 | 1.08 | 57% |
| Annual Report Gross Expense Ratio | 0.62 | 1.10 | 56% |
| Fund Existence | 9 years | 21 years | - |
| Gain YTD | 14.707 | 10.984 | 134% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 844M | 43.7B | 2% |
| Annual Yield % from dividends | 1.05 | 1.83 | 57% |
| Returns for 1 year | 21.64 | 18.20 | 119% |
| Returns for 3 years | 57.99 | 44.32 | 131% |
| Returns for 5 years | 26.88 | 31.41 | 86% |
| Returns for 10 years | N/A | 121.95 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LAVQX | 17.11 | 0.03 | +0.18% |
| Lord Abbett Fundamental Equity R2 | |||
| RLSMX | 13.63 | 0.02 | +0.15% |
| Lazard US Small Cap Equity Select R6 | |||
| FKMCX | 51.05 | 0.06 | +0.12% |
| Fidelity Mid-Cap Stock K | |||
| PARNX | 56.13 | 0.06 | +0.11% |
| Parnassus Mid Cap Growth Investor | |||
| FRMPX | 29.29 | -0.30 | -1.01% |
| Nuveen Small Cap Growth Opp A | |||